Since magnesium is involved in the regulation of insulin signaling, leptin metabolism, and the immune response, we hypothesize that supplementation with magnesium in this population would help increase the efficiency of radiation therapy and tumor response by reducing levels of inflammatory markers and improving insulin response, thereby preventing tumor progression, reducing toxicities, and improving breast cancer outcomes in this population. This evidence concerns the gene INS and neoplasm.